Abstract
Purpose of Review
Drug-induced sleep endoscopy (DISE) provides additional information about upper airway sites and patterns of narrowing in obstructive sleep apnea. There is a great variability on drugs chosen for DISE in the literature. In this systematic review, we looked for differences in obstruction patterns, as well as cardiovascular, neurological, or respiratory differences between the different drugs.
Recent Findings
All drugs reproduced a similar upper airway collapse on DISE. Propofol and midazolam showed a higher rate of respiratory depression; however, propofol has better pharmacokinetic properties. Dexmedetomidine has a safer respiratory profile and diminishes nausea, cough, sneeze reflexes, and saliva secretion, but holds a lower cardiovascular security.
Summary
The ideal drug for DISE has not been found yet; each of these existing drugs has its advantages and disadvantages. The right drug should be chosen by the surgeon and/or the anesthetists’ preferences and the patient’s condition.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Kezirian EJ. Drug-induced sleep endoscopy. Oper Tech Otolaryngol Head Neck Surg. 2006;17:230–2. https://doi.org/10.1016/j.otot.2006.10.005.
• Ehsan Z, Mahmoud M, Shott SR, et al. The effects of anesthesia and opioids on the upper airway: a systematic review. Laryngoscope. 2016;126:270–84. https://doi.org/10.1002/lary.25399Systematic review of the cardiac and UA effects of multiple drugs used for sedation in DISE. Propofol produces a collapse of the UA that is dose dependent; dexmedetomidine has the lowest inhibitory effect on the respiratory center.
• Shteamer JW, Dedhia RC. Sedative choice in drug-induced sleep endoscopy: a neuropharmacology-based review. Laryngoscope. 2017;127:273–9. https://doi.org/10.1002/lary.26132Systematic review of the articles published before 2016. Even though neither of the drugs could reproduce the exact respiration of natural sleep, dexmedetomidine has a neuropharmacological profile promising to reproduce natural sleep.
Liu L, Wu AP, Yang Y, Liu SQ, Huang YZ, Xie JF, et al. Effects of propofol on respiratory drive and patient-ventilator synchrony during pressure support ventilation in postoperative patients: a prospective study. Chin Med J. 2017;130:1155–60. https://doi.org/10.4103/0366-6999.205864.
Genta PR, Eckert DJ, Gregorio MG, Danzi NJ, Moriya HT, Malhotra A, et al. Critical closing pressure during midazolam-induced sleep. J Appl Physiol. 2011;111:1315–22. https://doi.org/10.1152/japplphysiol.00508.2011.
De Vito A, Carrasco Llatas M, Ravesloot MJ, et al. European position paper on drug-induced sleep endoscopy: 2017 Update. 2018.
Cho JS, Soh S, Kim EJ, Cho HJ, Shin S, Kim HJ, et al. Comparison of three sedation regimens for drug-induced sleep endoscopy. Sleep Breath. 2015;19:711–7. https://doi.org/10.1007/s11325-015-1127-9.
•• Chang ET, Certal V, Song SA, et al. Dexmedetomidine versus propofol during drug-induced sleep endoscopy and sedation: a systematic review. Sleep Breath. 2017;21:727–35. https://doi.org/10.1007/s11325-017-1465-xSystematic review of the articles published before 2016. Propofol has a quicker start of action and shorter half-life and it is capable of reproducing UA collapse, although the cardiorespiratory profile is less stable than that with dexmedetomidine.
Griffin CE, Kaye AM, Rivera Bueno F, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13:214–23.
Forster A, Gardaz J-P, Suter PM, Gemperle M. Respiratory depression by midazolam and diazepam. Anesthesiology. 1980;53:494–7.
•• Viana A, Zhao C, Rosa T, et al. The effect of sedating agents on drug-induced sleep endoscopy findings. Laryngoscope. 2019;129:506–13. https://doi.org/10.1002/lary.27298The only prospective study comparing the 3 drugs regarding UA collapse and respiratory profile. Propofol and midazolam produced an increased collapse at the tongue base and lower O2 saturation than dexmedetomidine.
• Yoon BW, Hong JM, Hong SL, et al. A comparison of dexmedetomidine versus propofol during drug-induced sleep endoscopy in sleep apnea patients. Laryngoscope. 2016;126:763–7. https://doi.org/10.1002/lary.25801Prospective study comparing UA collapse and cardiopulmonary profile with propofol and dexmedetomidine in the same group of OSA patients. The collapse was equal with both drugs but dexmedetomidine produced lower respiratory depression.
Carrasco M, Agostini G, Cuesta MT, et al. Drug-induced sleep endoscopy: a two drug comparison and simultaneous polysomnography. Eur Arch Oto-Rhino-Laryngol. 2014;271:181–7. https://doi.org/10.1007/s00405-013-2548-3.
Norton JR, Ward DS, Karan S, Voter WA, Palmer L, Varlese A, et al. Differences between midazolam and propofol sedation on upper airway collapsibility using dynamic negative airway pressure. Anesthesiology. 2006;104:1155–64. https://doi.org/10.1097/00000542-200606000-00009.
• Kasuya Y, Govinda R, Rauch S, et al. The correlation between bispectral index and observational sedation scale in volunteers sedated with dexmedetomidine and propofol. Anesth Analg. 2009;109:1811–5. https://doi.org/10.1213/ANE.0b013e3181c04e58Prospective study comparing propofol and dexmedetomidine in the same group of 19 volunteers. Propofol produced a higher respiratory depression; and dexmedetomidine, a deeper cardiac depression.
Lodenius Å, Ebberyd A, Hårdemark Cedborg A, Hagel E, Mkrtchian S, Christensson E, et al. Sedation with dexmedetomidine or propofol impairs hypoxic control of breathing in healthy male volunteers. Anesthesiology. 2016;125:700–15. https://doi.org/10.1097/ALN.0000000000001236.
Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, et al. Dexmedetomidine pharmacodynamics: part I - crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004;101:1066–76. https://doi.org/10.1097/00000542-200411000-00005.
• Abdullah VJ, Lee DLY, Ha SCN, Van Hasselt CA. Sleep endoscopy with midazolam: sedation level evaluation with bispectral analysis. Otolaryngol - Head Neck Surg (United States). 2013;148:331–7. https://doi.org/10.1177/0194599812464865Prospective study that compares sleep stages and UA collapse between midazolam and natural sleep. Midazolam was equivalent to natural sleep during N1 and N2 and muscle relaxation was not increased by midazolam.
•• Ordones AB, Grad GF, Cahali MB, et al. Comparison of upper airway obstruction during zolpidem-induced sleep and propofol-induced sleep in patients with obstructive sleep apnea: a pilot study. J Clin Sleep Med. 2020;16:725–32. https://doi.org/10.5664/jcsm.8334Prospective study comparing propofol- and zolpidem-induced sleep in OSA patients. There were no significant differences in any of the parameters studied.
Rabelo FAW, Küpper DS, Sander HH, Fernandes RMF, Valera FCP. Polysomnographic evaluation of propofol-induced sleep in patients with respiratory sleep disorders and controls. Laryngoscope. 2013;123:2300–5. https://doi.org/10.1002/lary.23664.
Abdelgalel EF. Dexmedetomidine added to propofol for drug-induced sleep endoscopy in adult patients with obstructive sleep apnea: randomized controlled trial. Egypt J Anaesth. 2018;34:151–7. https://doi.org/10.1016/j.egja.2018.09.001.
Padiyara TV, Bansal S, Jain D, Arora S, Gandhi K. Dexmedetomidine versus propofol at different sedation depths during drug-induced sleep endoscopy: a randomized trial. Laryngoscope. 2020;130:257–62. https://doi.org/10.1002/lary.27903.
Zhao LL, Liu H, Zhang YY, Wei JQ, Han Y, Han L, et al. A comparative study on efficacy and safety of propofol versus dexmedetomidine in sleep apnea patients undergoing drug-induced sleep endoscopy: a consort-prospective, randomized, controlled clinical trial. Biomed Res Int. 2018;2018:10–5. https://doi.org/10.1155/2018/8696510.
Wu W, Chen Q, Zhang L c, Chen W h. Dexmedetomidine versus midazolam for sedation in upper gastrointestinal endoscopy. J Int Med Res. 2014;42:516–22. https://doi.org/10.1177/0300060513515437.
Capasso R, Rosa T, Tsou DYA, Nekhendzy V, Drover D, Collins J, et al. Variable findings for drug-induced sleep endoscopy in obstructive sleep apnea with propofol versus dexmedetomidine. Otolaryngol - Head Neck Surg (United States). 2016;154:765–70. https://doi.org/10.1177/0194599815625972.
De Vito A, Agnoletti V, Berrettini S, et al. Drug-induced sleep endoscopy: conventional versus target controlled infusion techniques-a randomized controlled study. Eur Arch Oto-Rhino-Laryngol. 2011;268:457–62. https://doi.org/10.1007/s00405-010-1376-y.
Elkalla RS, El Mourad MB. Respiratory and hemodynamic effects of three different sedative regimens for drug induced sleep endoscopy in sleep apnea patients. A prospective randomized study. Minerva Anestesiol. 2020;86:132–40. https://doi.org/10.23736/S0375-9393.19.13875-8.
Kim N, Yoo YC, Lee SK, Kim H, Ju HM, Min KT. Comparison of the efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil during endoscopic submucosal dissection. World J Gastroenterol. 2015;21:3671–8. https://doi.org/10.3748/wjg.v21.i12.3671.
Shin HJ, Kim EY, Hwang JW, Do SH, Na HS. Comparison of upper airway patency in patients with mild obstructive sleep apnea during dexmedetomidine or propofol sedation: a prospective, randomized, controlled trial. BMC Anesthesiol. 2018;18:1–7. https://doi.org/10.1186/s12871-018-0586-5.
Kim Y, Park H, Shin J, Choi JH, Park SW, Kang HY. Effect of remifentanil during drug-induced sleep endoscopy in patients with obstructive sleep apnea. Sleep Breath. 2018;22:919–23. https://doi.org/10.1007/s11325-018-1738-z.
Kuyrukluyıldız U, Binici O, Onk D, Ayhan Celik S, Torun MT, Unver E, et al. Comparison of dexmedetomidine and propofol used for drug-induced sleep endoscopy in patients with obstructive sleep apnea syndrome. Int J Clin Exp Med. 2015;8:5691–8.
Murabito P, Serra A, Zappia M, Maiolino L, Cocuzza S, Castorina S, et al. Comparison of genioglossus muscle activity and efficiency of dexmedetomidine or propofol during drug-induced sleep endoscopy in patients with obstructive sleep apnea/hypopnea syndrome. Eur Rev Med Pharmacol Sci. 2019;23:389–96. https://doi.org/10.26355/eurrev_201901_16787.
Eastwood PR, Platt PR, Shepherd K, Maddison K, Hillman DR. Collapsibility of the upper airway at different concentrations of propofol anesthesia. Anesthesiology. 2005;103:470–7. https://doi.org/10.1097/00000542-200509000-00007.
Genta PR, Edwards BA, Sands SA, Owens RL, Butler JP, Loring SH, et al. Tube law of the pharyngeal airway in sleeping patients with obstructive sleep apnea. Sleep. 2016;39:337–43. https://doi.org/10.5665/sleep.5440.
Oshima T, Masaki Y, Toyooka H. Flumazenil antagonizes midazolam-induced airway narrowing during nasal breathing in humans. Br J Anaesth. 1999;82:698–702. https://doi.org/10.1093/bja/82.5.698.
Chattopadhyay U, Mallik S, Ghosh S, et al. Comparison between propofol and dexmedetomidine on depth of anesthesia: a prospective randomized trial. J Anaesthesiol Clin Pharmacol. 2014;30:550–4. https://doi.org/10.4103/0970-9185.142857.
Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56:893–913. https://doi.org/10.1007/s40262-017-0507-7.
Kellner P, Herzog B, Plößl S, Rohrmeier C, Kühnel T, Wanzek R, et al. Depth-dependent changes of obstruction patterns under increasing sedation during drug-induced sedation endoscopy: results of a German monocentric clinical trial. Sleep Breath. 2016;20:1035–43. https://doi.org/10.1007/s11325-016-1348-6.
Hong SD, Dhong HJ, Kim HY, Sohn JH, Jung YG, Chung SK, et al. Change of obstruction level during drug-induced sleep endoscopy according to sedation depth in obstructive sleep apnea. Laryngoscope. 2013;123:2896–9. https://doi.org/10.1002/lary.24045.
Heiser C, Fthenakis P, Hapfelmeier A, Berger S, Hofauer B, Hohenhorst W, et al. Drug-induced sleep endoscopy with target-controlled infusion using propofol and monitored depth of sedation to determine treatment strategies in obstructive sleep apnea. Sleep Breath. 2017;21:737–44. https://doi.org/10.1007/s11325-017-1491-8.
Lo YL, Ni YL, Wang TY, Lin TY, Li HY, White DP, et al. Bispectral index in evaluating effects of sedation depth on drug-induced sleep endoscopy. J Clin Sleep Med. 2015;11:1011–20. https://doi.org/10.5664/jcsm.5016.
Demiraran Y, Korkut E, Tamer A, Yorulmaz I, Kocaman B, Sezen G, et al. The comparison of dexmedetomidine and midazolam used for sedation of patients during upper endoscopy: a prospective, randomized study. Can J Gastroenterol. 2007;21:25–9. https://doi.org/10.1155/2007/350279.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on SLEEP MEDICINE: Sleep Apnea
Rights and permissions
About this article
Cite this article
Matarredona-Quiles, S., Pérez-Carbonell, T., Ortega-Beltrá, N. et al. Is There a Perfect Drug for Sedation in DISE?. Curr Otorhinolaryngol Rep 9, 260–270 (2021). https://doi.org/10.1007/s40136-021-00355-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40136-021-00355-5